These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26596950)

  • 61. Design, synthesis and trypanocidal activity of lead compounds based on inhibitors of parasite glycolysis.
    Nowicki MW; Tulloch LB; Worralll L; McNae IW; Hannaert V; Michels PA; Fothergill-Gilmore LA; Walkinshaw MD; Turner NJ
    Bioorg Med Chem; 2008 May; 16(9):5050-61. PubMed ID: 18387804
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Trypanocidal activity of methylene blue. Evidence for in vitro efficacy and in vivo failure.
    Boda C; Enanga B; Courtioux B; Breton JC; Bouteille B
    Chemotherapy; 2006; 52(1):16-9. PubMed ID: 16340192
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.
    Huang TL; Bacchi CJ; Kode NR; Zhang Q; Wang G; Yartlet N; Rattendi D; Londono I; Mazumder L; Vanden Eynde JJ; Mayence A; Donkor IO
    Int J Antimicrob Agents; 2007 Dec; 30(6):555-61. PubMed ID: 17920820
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Distinct activation mechanisms trigger the trypanocidal activity of DNA damaging prodrugs.
    Meredith EL; Kumar A; Konno A; Szular J; Alsford S; Seifert K; Horn D; Wilkinson SR
    Mol Microbiol; 2017 Oct; 106(2):207-222. PubMed ID: 28792090
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacomodulations on new organometallic complexes of Ir, Pt, Rh, Pd, Os: in vitro and in vivo trypanocidal study against Trypanosoma brucei brucei.
    Loiseau PM; Craciunescu DG; Doadrio-Villarejo JC; Certad-Fombona G; Gayral P
    Trop Med Parasitol; 1992 Jun; 43(2):110-4. PubMed ID: 1519021
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vitro effect of alkaloids on bloodstream forms of Trypanosoma brucei and T. congolense.
    Merschjohann K; Sporer F; Steverding D; Wink M
    Planta Med; 2001 Oct; 67(7):623-7. PubMed ID: 11582539
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites.
    Hall BS; Bot C; Wilkinson SR
    J Biol Chem; 2011 Apr; 286(15):13088-95. PubMed ID: 21345801
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Contribution of N,N'-dialkylbenzamide groups to trypanocidal properties of spiroarsoranes.
    Loiseau PM; Bories C; Trabelsi M; Gayral P; Wolf JG
    Parasitol Res; 1994; 80(8):708-10. PubMed ID: 7886045
    [No Abstract]   [Full Text] [Related]  

  • 69. In vitro antitrypanosomal activity of five low-MW antibiotics.
    Ishiyama A; Otoguro K; Iwatsuki M; Namatame M; Nishihara-Tsukashima A; Takahashi Y; Onodera H; Yamada H; Omura S
    J Antibiot (Tokyo); 2012 Feb; 65(2):113-4. PubMed ID: 22167160
    [No Abstract]   [Full Text] [Related]  

  • 70. Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agents.
    Ohkanda J; Buckner FS; Lockman JW; Yokoyama K; Carrico D; Eastman R; de Luca-Fradley K; Davies W; Croft SL; Van Voorhis WC; Gelb MH; Sebti SM; Hamilton AD
    J Med Chem; 2004 Jan; 47(2):432-45. PubMed ID: 14711313
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Synthesis and evaluation of analogs of the phenylpyridazinone NPD-001 as potent trypanosomal TbrPDEB1 phosphodiesterase inhibitors and in vitro trypanocidals.
    Veerman J; van den Bergh T; Orrling KM; Jansen C; Cos P; Maes L; Chatelain E; Ioset JR; Edink EE; Tenor H; Seebeck T; de Esch I; Leurs R; Sterk GJ
    Bioorg Med Chem; 2016 Apr; 24(7):1573-81. PubMed ID: 26935942
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lead optimization of selective tubulin inhibitors as anti-trypanosomal agents.
    Zhao A; Li Y; Orahoske CM; Schnur B; Sabbagh A; Zhang W; Li B; Su B
    Bioorg Med Chem; 2019 Apr; 27(8):1517-1528. PubMed ID: 30833159
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Development of novel 1,4-benzodiazepine-based Michael acceptors as antitrypanosomal agents.
    Ettari R; Previti S; Cosconati S; Maiorana S; Schirmeister T; Grasso S; Zappalà M
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3453-6. PubMed ID: 27372809
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synthesis and biological evaluation of polyalthic acid derivatives for the treatment of neglected diseases.
    Mizuno CS; Souza AB; Tekwani BL; Ambrósio SR; Veneziani RC
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5529-31. PubMed ID: 26520665
    [TBL] [Abstract][Full Text] [Related]  

  • 75. DNA binding affinity of bisguanidine and bis(2-aminoimidazoline) derivatives with in vivo antitrypanosomal activity.
    Dardonville C; Barrett MP; Brun R; Kaiser M; Tanious F; Wilson WD
    J Med Chem; 2006 Jun; 49(12):3748-52. PubMed ID: 16759117
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synthesis, Structure and In Vitro Anti-Trypanosomal Activity of Non-Toxic Arylpyrrole-Based Chalcone Derivatives.
    Zulu AI; Oderinlo OO; Kruger C; Isaacs M; Hoppe HC; Smith VJ; Veale CGL; Khanye SD
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32260364
    [TBL] [Abstract][Full Text] [Related]  

  • 77. New heterocyclic compounds: Synthesis and antitrypanosomal properties.
    Pomel S; Dubar F; Forge D; Loiseau PM; Biot C
    Bioorg Med Chem; 2015 Aug; 23(16):5168-74. PubMed ID: 25835356
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi.
    Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML
    ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Trypanocidal activity of peptidyl vinyl ester derivatives selective for inhibition of mammalian proteasome trypsin-like activity.
    Steverding D; Baldisserotto A; Wang X; Marastoni M
    Exp Parasitol; 2011 Aug; 128(4):444-7. PubMed ID: 21458452
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A class of 5-nitro-2-furancarboxylamides with potent trypanocidal activity against Trypanosoma brucei in vitro.
    Zhou L; Stewart G; Rideau E; Westwood NJ; Smith TK
    J Med Chem; 2013 Feb; 56(3):796-806. PubMed ID: 23281892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.